Cardio Med Medical Center
11
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Feasibility of 3D Printed Models of Aortic Stenosis in Guiding TAVI Procedure
Role: lead
CCTA Coronary Hemodynamics, Systemic Inflammation and Vulnerable Plaques (COHESIVE)
Role: lead
Assessment of Lesion-Associated Myocardial Ischemia Based on Fusion Coronary CT Imaging
Role: lead
Coronary Plaque Geometry and Acute Coronary Syndromes
Role: lead
Periodontal Disease, Inflammation and Acute Coronary Syndromes
Role: lead
Multiomics and Imaging-based Assessment of Vulnerable Coronary Plaques in Acute Coronary Syndromes
Role: lead
Impact of Cardiac Rehabilitation Programs on Left Ventricular Remodeling After Acute Myocardial Infarction - the REHAB Trial
Role: lead
Inflammation-mediated Coronary Plaque Vulnerability, Myocardial Viability and Ventricular Remodeling
Role: lead
Systemic, Pancoronary and Local Coronary Vulnerability
Role: lead
The Assessment Of Myocardial Viability Based On CTA/MRI Hybrid Models
Role: lead
Inflammation, Fibrosis and Risk of Recurrence After Atrial Fibrillation Ablation
Role: lead
All 11 trials loaded